The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms (BeneMin)
Sponsor: Cambridgeshire and Peterborough NHS Foundation Trust
Listed as NCT02928965, this PHASE2 trial focuses on Schizophrenia and Disorders With Psychotic Features and remains completed. Sponsored by Cambridgeshire and Peterborough NHS Foundation Trust, it has been updated 11 times since 2013, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Mar 2022 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Mar 2022 [monthly]
Completed PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 6 earlier versions
-
May 2019 — Sep 2019 [monthly]
Completed PHASE2
-
Feb 2019 — May 2019 [monthly]
Completed PHASE2
-
Nov 2018 — Feb 2019 [monthly]
Completed PHASE2
-
Jun 2018 — Nov 2018 [monthly]
Completed PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cambridgeshire and Peterborough NHS Foundation Trust
- Camden and Islington NHS Foundation Trust
- Central and North West London NHS Foundation Trust
- Greater Manchester Mental Health NHS Foundation Trust
- King's College London
- Lancashire Care NHS Foundation Trust
- Manchester Mental Health & Social Care Trust
- NHS Borders
- NHS Fife
- NHS Lothian
- North East London Foundation Trust
- Northern Care Alliance NHS Foundation Trust
- South London and Maudsley NHS Foundation Trust
- University College, London
- University Hospital Birmingham NHS Foundation Trust
- University of Birmingham
- University of Cambridge
- University of Edinburgh
- University of Manchester
- West London Mental Health NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.